FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

LAURUSLABS Share Price Discussion

Laurus Labs Ltd.
Sector: Pharmaceuticals and health care
... Read more
LAURUSLABS Share Price *
335 -5.2 (-1.53%)
* (quote may be delayed)

Find answers to all your questions on live LAURUSLABS message board: Is LAURUSLABS buy or sell? Should I buy LAURUSLABS shares? Why are LAURUSLABS shares falling? Should I invest in LAURUSLABS stock?


You can also check LAURUSLABS share price target recommended by brokerages.

LAURUSLABS Discussion Forum


LAURUS LABS LTD - FDA INSPECTION FOUND 3 OBSERVATIONS
1
reply
Reply
share
Share

Laurus Labs Q2: Net profit at Rs 55.6 crore versus Rs 16.2 crore despite a rise in tax expense & fall in other income.
Like
reply
Reply
share
Share
11 stocks where brokerages have initiated coverage this week, expect 13-38% returns
A lot of stocks have shown double digit growth in the last few sessions but it is never too late to invest, provided it is done after a thorough research.
Moneycontrol
Like
reply
Reply
share
Share
Stocks in the news: NALCO, Reliance Comm, NTCP, Laurus Labs, Tata Comm, RITES, Madhav Infra
Central Bank of India | Tata Communications | NALCO | RITES | NTPC and OBC are among stocks which are in news today.
Moneycontrol
Like
reply
Reply
share
Share
Stocks in the news: Central Bank of India, Tata Communications, NALCO, RITES, NTPC, OBC
Central Bank of India | Tata Communications | NALCO | RITES | NTPC and OBC are among stocks which are in news today.
Moneycontrol
Like
reply
Reply
share
Share

LAURUSLABS - 365801

Like
reply
Reply
share
Share
Trade Setup for Thursday: Top 14 things to know before Opening Bell
Other than geopolitical developments, the FOMC meet outcome will be a key factor.
Moneycontrol
Like
reply
Reply
share
Share
Laurus Labs gains 3% on EIR from USFDA for Vizag units
Laurus Labs is among the three companies to receive an approval for TLE 400, an antiretroviral therapy product
Moneycontrol
Like
reply
Reply
share
Share
Lovable Lingeri Standalone June 2019 Net Sales at Rs 52.58 crore, down 4.21% Y-o-Y
moneycontrol.com
Like
reply
Reply
share
Share

HDFC Securities is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 470 in its research report dated August 05, 2019.
Like
reply
Reply
share
Share
Buy Laurus Labs; target of Rs 470: HDFC Securities
HDFC Securities is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 470 in its research report dated August 05, 2019.
moneycontrol.com
Like
reply
Reply
share
Share
Laurus Labs Q1: Impacted by transition in ARV-API business; strong traction in formulation is positive
moneycontrol.com
Like
reply
Reply
share
Share
Stocks in the news: ITC, RIL, Nestle, NIIT, Coffee Day, DHFL, Union Bank, Bata India, JK Cement
Nestle India | NIIT | Coffee Day Enterprises | DHFL | Union Bank | Bata India and JK Cement are stocks which are in the news today.
www.moneycontrol.com
Like
reply
Reply
share
Share
Trade Setup for Monday: Top 15 things to know before Opening Bell
Jimeet Modi of SAMCO Securities said volatility has increased giving intraday traders good opportunities provided they are on the right side of the market
www.moneycontrol.com
Like
reply
Reply
share
Share
Laurus Labs Q1 PAT down 9% at Rs 15 Cr
Satyanarayana Chava CEO said the API (Active Pharmaceutical Ingredients) Generics business witnessed a slowdown mainly because of lower ARV (antiretroviral) and Hepatitis C API sales.
moneycontrol.com
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
  • LAURUSLABS - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization4,254.94
    Enterprise Value5,170.37
    Price to Earnings30.81
    Price to Book Value2.68
    Return on Capital Employed0.13
    Return on Equity0.11
    Face Value10
    Dividend YieldNA
  • LAURUSLABS Share Price - Technicals

    keyboard_arrow_down
    LAURUSLABS - 52 Week High₹418.8
    LAURUSLABS - 52 Week Low₹303.3
  • LAURUSLABS - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    5-Aug-19HDFC SecuritiesBuy471
    17-Jul-19HDFC SecuritiesBuy515
    1-Jul-19Kotak SecuritiesBuy430
    6-May-19Motilal OswalBuy470
    26-Apr-19HDFC SecuritiesBuy417
    LAURUSLABS Brokerage Price Target
  • LAURUSLABS Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Dec 9337.15340.15331.5335.35
    Dec 6346.3346.3338340.2
    Dec 5337347.9337343.8
    Dec 4340.85348335.35336.55
    Dec 3345.6347.5339340.6
  • LAURUSLABS Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹343.94
    30 Day Moving Average₹350.73
    50 Day Moving Average₹346.87
    100 Day Moving Average₹342.63
    200 Day Moving Average₹353.74
  • LAURUSLABS - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue2,039.291,891.920.08
    Operating Profit408.75415.62-0.02
    Profit Before Tax240.91247.63-0.03
    Net Income173.14202.57-0.15
  • LAURUSLABS - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds1,5901,513.30.05
    Total Liabilities1,7271,612.410.07
    Total Assets3,3183,125.710.06
  • LAURUSLABS - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity368.6320.060.15
    Cash from Investing Activity-417.48-280.950.49
    Cash from Financing Activity48.99-47.31-2.04
    Net Cash Flow0.12-8.21-1.01
  • LAURUSLABS - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.060.08
    Return on Equity0.110.15
    Return on Capital Employed0.130.16
  • LAURUSLABS - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.54
    3 Year CAGR Growth in Operating Profit0.99
    3 Year CAGR Growth in EBIDTA0.83
    3 Year CAGR Growth in Net Income1.36
    3 Yr CAGR Growth - Diluted EPS0.82
  • LAURUSLABS - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue1.82
    5 Year CAGR Growth in Operating Profit1.82
    5 Year CAGR Growth in EBIDTA1.92
    5 Year CAGR Growth in Net Income0.96
    3 Yr CAGR Growth - Diluted EPS0.44
  • LAURUSLABS - Recent News

    keyboard_arrow_down
    NewsBot
    Sep 26 9:58 PM
    11 stocks where brokerages have initiated coverage this week, expect 13-38% returns
    Moneycontrol
    NewsBot
    Sep 19 1:48 PM
    Stocks in the news: NALCO, Reliance Comm, NTCP, Laurus Labs, Tata Comm, RITES, Madhav Infra
    Moneycontrol
    NewsBot
    Sep 19 1:28 PM
    Stocks in the news: Central Bank of India, Tata Communications, NALCO, RITES, NTPC, OBC
    Moneycontrol
    NewsBot
    Sep 19 2:18 AM
    Trade Setup for Thursday: Top 14 things to know before Opening Bell
    Moneycontrol
    NewsBot
    Sep 5 4:38 PM
    Laurus Labs gains 3% on EIR from USFDA for Vizag units
    Moneycontrol
    NewsBot
    Aug 12 9:28 PM
    Lovable Lingeri Standalone June 2019 Net Sales at Rs 52.58 crore, down 4.21% Y-o-Y
    moneycontrol.com
    NewsBot
    Aug 7 10:53 PM
    Buy Laurus Labs; target of Rs 470: HDFC Securities
    moneycontrol.com
    NewsBot
    Aug 6 7:28 PM
    Laurus Labs Q1: Impacted by transition in ARV-API business; strong traction in formulation is positive
    moneycontrol.com
    NewsBot
    Aug 5 1:13 PM
    Stocks in the news: ITC, RIL, Nestle, NIIT, Coffee Day, DHFL, Union Bank, Bata India, JK Cement
    www.moneycontrol.com
    NewsBot
    Aug 5 12:33 AM
    Trade Setup for Monday: Top 15 things to know before Opening Bell
    www.moneycontrol.com
  • LAURUSLABS - Related Communities

    keyboard_arrow_down
    Wanbury Ltd. Sector: Pharmaceuticals ...
    Piramal Phytocare Ltd. Sector: Pharma...
    Parabolic Drugs Ltd. Sector: Pharmace...
    Orchid Pharma Ltd. Sector: Pharmaceut...
    Biofil Chemicals & Pharmaceuticals Lt...
    Wockhardt Ltd. Sector: Pharmaceutical...
    Vivimed Labs Ltd. Sector: Pharmaceuti...
    Venus Remedies Ltd. Sector: Pharmaceu...
    Unichem Laboratories Ltd. Sector: Pha...
    TTK Healthcare Ltd. Sector: Pharmaceu...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.